2023
Effect of Complementary Interventions to Redesign Care on Teamwork and Quality for Hospitalized Medical Patients : A Pragmatic Controlled Trial.
O'Leary K, Johnson J, Williams M, Estrella R, Hanrahan K, Leykum L, Smith G, Goldstein J, Kim J, Thompson S, Terwilliger I, Song J, Lee J, Manojlovich M. Effect of Complementary Interventions to Redesign Care on Teamwork and Quality for Hospitalized Medical Patients : A Pragmatic Controlled Trial. Annals Of Internal Medicine 2023, 176: 1456-1464. PMID: 37903367, DOI: 10.7326/m23-0953.Peer-Reviewed Original ResearchConceptsLength of stayAdverse eventsHealth care professionalsPatient outcomesImplementation of interventionsMedical patientsTeamwork climateCare professionalsPatient experienceHospitalized medical patientsHospital care deliveryImproved patient outcomesTeamwork climate scoresHigh-quality careEffects of interventionsPatient engagement activitiesA PragmaticSecondary outcomesHospitalized patientsPrimary outcomeInterprofessional roundsPatientsMedical unitsPhysician teamCare delivery
2021
517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial
Branch-Elliman W, Ferguson R, Doros G, Woods P, Leatherman S, Strymish J, Datta R, Goswami R, Jankowich M, Shah N, Taylor T, Page S, Schiller S, Shannon C, Hau C, Flynn M, Holmberg E, Visnaw K, Dhond R, Brophy M, Monach P. 517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial. Open Forum Infectious Diseases 2021, 8: 360-360. PMCID: PMC8690689, DOI: 10.1093/ofid/ofab466.716.Peer-Reviewed Original ResearchSubcutaneous sarilumabStandard careMechanical ventilationLearning healthcare systemClinical trialsSevere COVID-19 diseaseCOVID-19Rate of intubationSevere COVID-19Trial of patientsCare clinical trialsIL-6 inhibitionTreatment of patientsNumber of patientsStandard of careHealthcare systemEvidence of benefitCOVID-19 diseaseData monitoring committeeA PragmaticPrimary endpointChart reviewHospitalized patientsPrimary outcomeSupplemental oxygen
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply